Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2012
09/05/2012CN101870692B Novel piperazinyl pyridazine compounds
09/05/2012CN101624367B Chiral carbazole-4-ketone derivative, preparation method thereof and R(-)ondansetron prepared by the compound
09/05/2012CN101580521B Dendritic organic metal composition and electroluminescent device using same
09/05/2012CN101563319B Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
09/05/2012CN101528688B Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates
09/05/2012CN101511359B Benzotriazole kinase modulators
09/05/2012CN101370799B Cis-4, 5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors
09/05/2012CN101279970B 2-methyl-5-azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutied derivate, preparation and application thereof
09/05/2012CN101268070B Novel sulphonylpyrroles as inhibitors of HDAC novel sulphonylpyrroles
09/04/2012US8258175 Isoindolin-1-one derivatives
09/04/2012US8258139 Method of treatment for mental disorders
09/04/2012US8258130 Pyrimidine hydrazide compounds as PGDS inhibitors
08/2012
08/30/2012WO2012116279A1 Cannabinoid receptor modulators
08/30/2012WO2012116276A1 Crystalline forms and processes for the preparation of condensed azacycles ( cannabinoid receptor modulators)
08/30/2012WO2012116257A1 Anti-viral compounds
08/30/2012WO2012115480A2 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012WO2012115478A2 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012WO2012115066A1 Glycine transport inhibitor
08/30/2012WO2012114273A1 An improved process for the preparation of voriconazole and intermediates thereof
08/30/2012WO2012113967A1 Gsk-3 inhibitors that can be used in neurodegenerative and inflammatory diseases, cancer, diabetes and in regenerative processes
08/30/2012US20120220783 Salts of sunitinib
08/30/2012US20120220771 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
08/30/2012US20120220769 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
08/30/2012US20120220622 Heterocyclic derivatives
08/30/2012US20120220604 Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/30/2012US20120220600 N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl) -1--1-methyl-urea
08/30/2012US20120220596 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
08/30/2012US20120220562 Anti-Viral Compounds
08/30/2012US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives
08/30/2012US20120220550 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
08/30/2012US20120219594 Benzimidazole-imidazole Derivatives
08/30/2012US20120219593 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
08/30/2012US20120217485 Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/30/2012US20120217483 Quinone Compounds as Dopants in Organic Electronics
08/30/2012US20120217449 Materials for electronic devices
08/30/2012CA2828495A1 Anti-viral compounds
08/30/2012CA2827379A1 An improved process for the preparation of voriconazole and intermediates thereof
08/30/2012CA2827072A1 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012CA2827057A1 Crystalline forms and processes for the preparation of condensed azacycles (cannabinoid receptor modulators)
08/30/2012CA2827030A1 Diaminopyrimidine derivatives and processes for the preparation thereof
08/29/2012EP2492267A1 Indole derivatives as CRTH2 receptor antagonists in combination with a second active ingredient
08/29/2012EP2492264A2 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
08/29/2012EP2492263A1 Pyridizinone Derivatives
08/29/2012EP2491030A1 Fused ring analogues of anti-fibrotic agents
08/29/2012EP2491026A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
08/29/2012EP2491022A1 Diazepam derivatives as modulators of chemokine receptors
08/29/2012EP2490529A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/29/2012CN101830853B Nitroimidazoline derivatives and preparation method thereof and application thereof
08/29/2012CN101486708B 4-nitro glyoxaline compound, preparation and use thereof
08/29/2012CN101486707B 2-methyl-5-nitro glyoxaline compound, preparation and use thereof
08/29/2012CN101155789B 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
08/28/2012US8252941 Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates
08/28/2012US8252932 Modified carbocyanine dyes and their conjugates
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252825 Angiotensin II receptor antagonists
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252802 Chemical compounds
08/28/2012US8252798 Purine compounds
08/28/2012US8252786 Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
08/28/2012US8252781 1,2-diazetidin-3-one derivatives and drugs containing same
08/28/2012CA2671744C Compounds and compositions as protein kinase inhibitors
08/28/2012CA2656079C Cyclic amine compound
08/28/2012CA2651378C Fxr agonists
08/28/2012CA2589744C Pyrrolinidium derivatives as m3 muscarinic receptors
08/28/2012CA2566846C Pdk-1/akt signaling inhibitors
08/23/2012WO2012112946A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012WO2012112689A1 Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers
08/23/2012WO2012111449A1 Method for producing aromatic compound having ring structure that includes nitrogen atom or oxygen atom
08/23/2012WO2012089633A9 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
08/23/2012WO2012078005A3 Compounds having hole conducting property, co-adsorbent body comprising same, and dye-sensitized solar cell comprising the co-adsorbent body
08/23/2012WO2011057706A8 Materials for electronic devices
08/23/2012US20120215005 High Stability Diionic Liquid Salts
08/23/2012US20120214993 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
08/23/2012US20120214991 Indenone Derivative and Pharmaceutical Composition Comprising Same
08/23/2012US20120214817 Urotensin ii receptor antagonists
08/23/2012US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/23/2012US20120214811 Raf inhibitor compounds and methods of use thereof
08/23/2012US20120214789 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
08/23/2012US20120214786 New compounds
08/23/2012US20120214766 Cannabinoid receptor modulators
08/23/2012US20120214762 6,5-heterocyclic propargylic alcohol compounds and uses therefor
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213795 Compositions and methods for inhibition of the jak pathway
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120213733 Anti-infective agents and uses thereof
08/23/2012US20120213729 Compounds for the Treatment of Hepatitis C
08/23/2012US20120213702 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/23/2012US20120211736 Compound for organic photoelectric device and organic photoelectric device including the same
08/23/2012US20120211701 Materials for electronic devices
08/23/2012CA2827724A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/22/2012EP2489664A1 Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same
08/22/2012EP2489663A1 Compounds as syk kinase inhibitors
08/22/2012EP2489657A2 Inhibitors of histone deacetylase
08/22/2012EP2488525A2 Antimicrobial compounds and methods of making and using the same
08/22/2012EP2488514A1 Indole and azaindole modulators of the alpha 7 nachr
08/22/2012EP2488511A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase
08/22/2012EP2488503A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
08/22/2012EP2488493A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 626